skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Greetings, Peter and Co.
I currently have 14.8% of my investments, excluding real estate and bullion, in the biotech/healthcare sector. I hold
Biosyent (RX) 0.5% (I have a considerable loss in RX.)
Concordia (CXR) – 1.5% (I expect CXR to be acquired by a larger company.)
Merus Labs (MSL) – 2.2%
Prometic (PLI) – 2.4%
Amgen (AMGN) – 3.1%
Knight (GUD) – 5.1%
I am considering liquidating my holdings in CXR, RX and perhaps MSL and using the proceeds to add to my PLI position and/or an alternative that you might recommend unless you think I am too overweight in this sector.
Thank you for your analysis and recommendations.
With appreciation
Ed
Read Answer Asked by Ed on April 25, 2016
Q: I would like to buy FNV. You say you are "very comfortable" with FNV. I've done some basic research and see that S&P Capital rates it a sell;TD as a hold; Thompson Reuters a buy. A news brief says "FNV files for mixed shelf of up to $2.0bln." INK Research shows that FNV insiders were doing lots of selling in March. HELP! How do I interpret all this?
Read Answer Asked by Elaine or Gerry on April 25, 2016
Q: Hi, 5i.

For pure utilities, I have BEP (2.0%) and RNW (1.5%). I also have ENB (2.0%) and IPL (1.0%) if you consider those utilities.

I'm looking to increase my utilities allocation and wondering if I should add to what I have or take a position in Fortis (or another name you recommend).

Thank you,
Robert
Read Answer Asked by Robert on April 25, 2016
Q: Hi, 5i.

What are your top picks for consumer staples at this time?

Thank you,
Robert
Read Answer Asked by Robert on April 25, 2016
Q: I have tried entering several symbols and I get, "a no questions asked".
I know on tgz, mux and tmm to name a few that you have answered questions in the past.
Am I doing something wrong. I specifically would like to know your opinion on ER Eastmain and the proposed changes in the works. And also to clear up what the problem is with the symbols I have entered. Thank You..
Read Answer Asked by Maureen on April 25, 2016
Q: Because of my age and possible future need for income, amount and security, I am pondering the addition of the following ETF’s. I am indicating the present and after purchase weighting in my portfolio. ZWU ( 3% - 5%), XHY (1% - 3%), XTR (0% - 5%). My portfolio is reasonably well
diversified with about 95% blue chip (28) common shares. Can you please comment on the appropriateness of my proposed purchases, given your limited knowledge of my portfolio.

The composition of XTR i shares includes other I share ETF’s so if I were to purchase this security I would be effectively duplicating management fees and further increase my exposure to XHY, which is held in XTR.

Thank you for considering this questions

Read Answer Asked by Gail on April 25, 2016
Q: Please give opinion on financial and momentuum strength of West Jet and future outlook, or any intrinsic or extrinsic to Canadian airline stocks

Please compare WestJet to the other airline in Canada as well

I have purchased at the bottom (@ about 15.50) and am concerned profit taking may cause a Drop ... noting last 2 days pullbacks

is there any typical seasonality to Canadian airlines?

Thankyou
Read Answer Asked by lyle on April 25, 2016
Q: What kind of long term dividend growth would you expect from this company? Can they keep up the historic 8% annually for the next ten years or is this asking too much. Their company presentation claims that they have a naturally higher ROE than other insurers. They do not seem to be aggressive investing their float like Fairfax is. Thanks.
Read Answer Asked by Michael on April 25, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!